Entera Bio annual gross margin
2020
2021
2022
2024
2025
Entera Bio Gross Margin Growth & History (ENTX)
Entera Bio's gross margin was 0.00% for fiscal 2025.
View full Entera Bio company overviewEntera Bio annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 0.00% | −4.97 pp |
| 2024 | 2024-12-31 | 4.97% | −19.65 pp |
| 2022 | 2022-12-31 | 24.63% | −10.05 pp |
| 2021 | 2021-12-31 | 34.68% | +16.87 pp |
| 2020 | 2020-12-31 | 17.81% | — |
Entera Bio quarterly gross margin
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q2.24
Q3.24
Q1.25
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q1 2025 | 2025-03-31 | 0.00% | −25.00 pp |
| Q3 2024 | 2024-09-30 | 0.00% | −25.00 pp |
| Q2 2024 | 2024-06-30 | 15.79% | −4.80 pp |
| Q4 2022 | 2022-12-31 | 42.86% | +25.28 pp |
| Q3 2022 | 2022-09-30 | 25.00% | −28.57 pp |
| Q2 2022 | 2022-06-30 | 25.00% | +15.83 pp |
| Q1 2022 | 2022-03-31 | 20.59% | −32.91 pp |
| Q4 2021 | 2021-12-31 | 17.58% | — |
| Q3 2021 | 2021-09-30 | 53.57% | — |
| Q2 2021 | 2021-06-30 | 9.17% | — |
| Q1 2021 | 2021-03-31 | 53.50% | — |
Entera Bio gross margin trends
Across the available reported history, Entera Bio's gross margin decreased from 4.97% to 0.00%, a change of −4.97 percentage points. The latest reported quarter, Q1 2025, shows 0.00%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Entera Bio filings at SEC.gov ↗